Crossmark

Reply to the comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting”

Published Print: 2015-11

Authors

Morais, João
License Information

Text and Data Mining valid from 2015-11-01

Version of Record valid from 2019-04-16
More Information

This article is maintained by: Elsevier

Article Title: Reply to the comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting”

Journal Title: Revista Portuguesa de Cardiologia (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repce.2015.09.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.repce.2015.09.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.repc.2015.06.008

Content Type: simple-article

Copyright: Copyright © 2015 Published by Elsevier España, S.L.

Document is current